{
  "docId": "019de515-3d1b-75a6-8859-e308ddafaf77",
  "docSlug": "63ac01720a7498aa205494557149c50f",
  "documentTitle": "Enfusion | Results Presentation Deck | 21 slides",
  "authorId": "enfusion",
  "authorName": "Enfusion",
  "documentKindSlug": "shareholder-letter",
  "documentKindLabel": "Shareholder letter",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 15,
  "pageCount": 21,
  "prevPage": 14,
  "nextPage": 16,
  "slideType": "other",
  "function": "other",
  "density": "dense",
  "nDataPoints": 38,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de515-3d1b-75a6-8859-e308ddafaf77/15",
  "deckHref": "/decks/019de515-3d1b-75a6-8859-e308ddafaf77",
  "deckJsonHref": "/decks/019de515-3d1b-75a6-8859-e308ddafaf77.json",
  "deckAnchorHref": "/decks/019de515-3d1b-75a6-8859-e308ddafaf77#slide-15",
  "components": [
    {
      "bbox": {
        "h": 0.025,
        "w": 0.058,
        "x": 0.04,
        "y": 0.933
      },
      "kind": "image",
      "text": null,
      "attrs": {},
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "76d1c06c-df47-4274-bc33-62efc0e4a367",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.011,
        "w": 0.015,
        "x": 0.936,
        "y": 0.933
      },
      "kind": "other",
      "text": "15",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d19cd736-73b0-4f5d-b11d-f0648b5d4fa3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.011,
        "w": 0.499,
        "x": 0.299,
        "y": 0.105
      },
      "kind": "paragraph",
      "text": "(dollars in thousands, except shares and unit amounts and par value) (Unaudited)",
      "attrs": {},
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "49f85b65-a649-4ce6-af55-25e0c15f55a8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.008,
        "w": 0.287,
        "x": 0.653,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "PROPRIETARY AND CONFIDENTIAL ©2023 ENFUSION, ALL RIGHTS RESERVED.",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dbf4bc08-3d8b-483e-8357-a6801a04e0c8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.726,
        "w": 0.586,
        "x": 0.209,
        "y": 0.16
      },
      "kind": "table",
      "text": "ASSETS Current Assets: Cash and cash equivalents $ 62,545 $ 64,365 Accounts receivable, net 25,855 18,223 Prepaid expenses 6,105 6,030 Other current assets 2,303 1,060 Total current assets 96,808 89,678 Property and equipment, net 15,759 13,051 Right of use asset 6,732 Other assets 4,484 3,356 Total assets $ 123,783 $ 106,085 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable $ 1,685 $ 2,528 Accrued expenses and other current liabilities 11,665 5,578 Lease liability - short term 4,030 Total current liabilities 17,380 8,106 Lease liability 2,959 Other liabilities 538 Total liabilities 20,339 8,644 Stockholders' Equity: Class A common stock, $0.001 par value; 1,000,000,000 shares authorized, 70,859,711 and 65,583,289 shares issued and outstanding as of December 31, 2022 and December 31, 2021, respectively 71 66 Class B common stock, $0.001 par value; 150,000,000 shares authorized, 43,198,768 and 47,470,972 shares issued and outstanding as of December 31, 2022 and December 31, 2021, respectively 43 47 Additional paid-in capital 244,260 226,717 Accumulated deficit (178,863) (171,209) Accumulated other comprehensive loss (504) (325) Total stockholders' equity attributable to Enfusion, Inc. 65,007 55,296 Non-controlling interests 38,437 42,145 Total stockholders' equity 103,444 97,441 Total liabilities and stockholders' equity $ 123,783 $ 106,085",
      "attrs": {},
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8653de32-0641-4844-8e14-06fb17d38dbc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.013,
        "w": 0.499,
        "x": 0.301,
        "y": 0.088
      },
      "kind": "title",
      "text": "ENFUSION, INC. CONSOLIDATED BALANCE SHEETS",
      "attrs": {},
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0d059194-3506-4152-ac12-b3b8772e1165",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Table data",
      "slug": "table-data",
      "agent": null,
      "layer": "slide",
      "matchId": "2a4ca940-018c-4b65-8344-445e77345c99",
      "evidence": "table/data: ASSETS Current Assets: Cash and cash equivalents $ 62,545 $ 64,365 Accounts receivable, net 25,855 18,223 Prepaid expenses 6,105 6,030 Other current assets 2,303 1,060 Total current assets 96,808 89,678 Prope",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}